MENU
+Compare
UEEC
Stock ticker: OTC
AS OF
Aug 26 closing price
Price
$0.09
Change
-$0.00 (-0.00%)
Capitalization
23.42M

UEEC stock forecast, quote, news & analysis

United Health Products Inc is a United States-based company... Show more

UEEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for UEEC with price predictions
Aug 26, 2025

UEEC's RSI Indicator ascending out of oversold territory

The RSI Indicator for UEEC moved out of oversold territory on July 25, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In of the 32 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on August 25, 2025. You may want to consider a long position or call options on UEEC as a result. In of 115 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UEEC just turned positive on July 29, 2025. Looking at past instances where UEEC's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where UEEC advanced for three days, in of 192 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

UEEC moved below its 50-day moving average on August 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for UEEC moved below the 200-day moving average on July 29, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UEEC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UEEC broke above its upper Bollinger Band on August 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for UEEC entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (10.908). P/E Ratio (0.000) is within average values for comparable stocks, (62.724). UEEC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.879). UEEC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.000) is also within normal values, averaging (38.486).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UEEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UEEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 11.04B. The market cap for tickers in the group ranges from 246 to 170.01B. ISRG holds the highest valuation in this group at 170.01B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 4%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 22%. STSS experienced the highest price growth at 90%, while FEMY experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 153%. For the same stocks of the Industry, the average monthly volume growth was 177% and the average quarterly volume growth was 121%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 65
Price Growth Rating: 60
SMR Rating: 80
Profit Risk Rating: 92
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
UEEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
520 Fellowship Road
Phone
+1 475 755-1005
Employees
7
Web
https://www.uhpcorp.com